SCHEMBL7724344

SCHEMBL7724344

O=C(Cl)C(c1ccccc1F)c1ccccc1F

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.48
CES1 P23141 2/20 0.48
ALDH1A1 P00352 1/20 0.48
ALOX15 P16050 1/20 0.48
GAA P10253 1/20 0.43
HDAC4 P56524 10/20 0.43
CNR2 P34972 2/20 0.42
HDAC3 O15379 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27819947 0.88 GAA (0.50) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL29362410 0.81 CES2 (0.61) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL1885454 0.81 CES2 (0.47) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL11000200 0.80 CES2 (0.50) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL2662687 0.79 CES2 (0.46) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL31414991 0.79 HIF1A (0.47) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL2527057 0.79 HIF1A (0.47) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL22917054 0.78 CES2 (0.48) CES2CES1ALDH1A1GAAHDAC4
SCHEMBL11043071 0.76 ACP3 (0.44) CES2CES1ALDH1A1HIF1A
SCHEMBL23032493 0.75 CES2 (0.46) CES2CES1GAAHDAC4CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468998-B1 ANTAGONIZE SEROTONIN 2 RECEPTORS, SUPPRESS PLATELET AGGREGATION, IMPROVE PERIPHERAL CIRCULATION AND PROMOTE LACHRYMATION MITSUBISHI PHARMA CORPORATION (JP) 2002-10-22 US disclosed
EP-1125922-A1 PYRROLIDINE COMPOUNDS AND MEDICINAL UTILIZATION THEREOF Welfide Corporation (JP) 2001-08-22 EP disclosed